Publications by authors named "Jingzhang Li"

Claim this Profile
F
First-Line Aumolertinib in -Mutant Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Retrospective Study with a Four-Year Follow-Up.
Xi Qin, Yulan Liu, Lin Zhu, Yunyan Mo, Jing Zhang, Jingzhang Li

Oncol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial.
Caicun Zhou, Ziping Wang, Meili Sun, Lejie Cao, Zhiyong Ma, Jiwei Liu, Yunpeng Liu, Xingya Li, Jingzhang Li, Changli Wang, Chunling Liu, Lin Li, Li Liang, Man Li

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC.
Caicun Zhou, Ziping Wang, Meili Sun, Lejie Cao, Zhiyong Ma, Jiwei Liu, Yunpeng Liu, Xingya Li, Jingzhang Li, Changli Wang, Chunling Liu

Nat Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Sheng Yang, Shiman Wu, Yanqiu Zhao, Gongyan Chen, Bo Zhu, Xingya Li, Liangming Zhang, Lin Wu, Meili Sun, Donglin Wang, Lijun Wang, Chunling Liu, Jingzhang Li, Jiwei Liu, Zili Meng, Zhefeng Liu, Zheng Liu, Shuliang Guo, Wen Li, Yingcheng Lin, Zhongliang Guo

Lung Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC.
Caicun Zhou, Ziping Wang, Meili Sun, Lejie Cao, Zhiyong Ma, Jiwei Liu, Yunpeng Liu, Xingya Li, Jingzhang Li, Changli Wang, Chunling Liu

Nat Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long non-coding RNA enhances gastric carcinoma proliferation, migration and invasion via the miR-136-5p/HOXC10 axis.
Jingzhang Li, Kai Sun, Mingming Zhang, Yusheng Luo, Ying Zhang, Wangjun Liao

Am J Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.
Xingsheng Hu, Shucai Zhang, Zhiyong Ma, Jifeng Feng, Lin Wu, Li Liu, Wangjun Liao, Chunling Liu, Jingzhang Li, Fei Liu

BMC Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study.
Yuankai Shi, Shiman Wu, Ke Wang, Shundong Cang, Wenxiu Yao, Lin Wu, Xingya Li, Meili Sun, Lijun Wang, Chunling Liu, Jingzhang Li, Jiwei Liu, Zili Meng, Zhefeng Liu, Zheng Liu, Shuliang Guo, Wen Li, Yingcheng Lin, Zhongliang Guo

J Thorac Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Kai Sun, Cheng Huang, Jing-Zhang Li, Zhan-Xiong Luo

World J Surg Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer.
Kai Sun, Ri-Xin Chen, Jing-Zhang Li, Zhan-Xiong Luo

Sci Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Kai Sun, Juan-Juan Hong, Dong-Mei Chen, Zhan-Xiong Luo, Jing-Zhang Li

BMC Gastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Dynamic and Static Obstructive Renal Artery on Early Prognosis in Stanford Type A Aortic Dissection.
Maozhou Wang, Lei Li, Jingzhang Li, Menghui Xu, Xin Pu, Qianxian Li, Lizhong Sun

Heart Lung Circ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Kai Sun, Ri-Xin Chen, Jing-Zhang Li, Zhan-Xiong Luo

Hereditas· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Yuankai Shi, Xingsheng Hu, Shucai Zhang, Dongqing Lv, Lin Wu, Li Liu, Chunling Liu, Jingzhang Li

Lancet Respir Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of Dual functional Nanobody-Nanoluciferase Fusion and its potential in Bioluminescence Enzyme Immunoassay for trace Glypican-3 in Serum.
Sheng Yu, Zhenfeng Li, Jingzhang Li, Shimei Zhao, Shanguang Wu, Hongjing Liu, Dongyang Li, Siliang Duan

Sens Actuators B Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines.
Jingzhang Li, Gangling Tong, Cheng Huang, Yunsheng Luo, Shubin Wang, Qiumei Liu, Min Li, Laiqing Li

J Cell Physiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells.
Gangling Tong, Boran Cheng, Jingzhang Li, Xuan Wu, Qiaohong Nong, Lirui He, Xi Li, Laiqing Li

Cancer Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis